-
Fri news: Gilead withdraws bladder cancer drug. Amgen and Intercept PDUFA date pushback. CVS replaces CEO. Supernus depression trial. AbbVie Parkinson’s approval. See more on our front page
Generic advair
- Thread starter anonymous
- Start date
-
- Tags
- None
was just going to post that.
Wonder what the #’s will look like for Symbicort? And if bleeding,how the brains at HQ will spin it?
Can’t help but wonder also what happens to the LABA/lama class if plans decide to step through generic Advair first. Who knows, Daliresp may become the lead product soon.
Wonder what the #’s will look like for Symbicort? And if bleeding,how the brains at HQ will spin it?
Can’t help but wonder also what happens to the LABA/lama class if plans decide to step through generic Advair first. Who knows, Daliresp may become the lead product soon.
I bet they have already spun off..lol! Bet they blame the field too! It’s always our fault
!!I bet they have already spun off..lol! Bet they blame the field too! It’s always our fault
AZ SSLT has planned for this market event. So, rest easy my friends. It's all part of the next phase of our journey as a company: Growth Through Innovation.
So now putting three old products together in one device is defined as "innovative"? My oh my how definitions change.
They are getting all of their business from Advair. Why are all you people freaking out. No doctor is going to write for Wixela instead of Symbicort. Lots of freaking out for nothing
You must be new. Doctors are definitely going to write Wixela instead of Symbicort when insurance companies start telling them the patient must try a generic first. Won't be long til this starts happening"
Already happening w/ some commercial payers. Will take longer for Med D due to contract obligations.
EL OH EL! Wait until the hospitals start booting Symbicort off formulary and replacing it with Wixela. Go away newbie. Let the adults talk.
Bottom line cost to managed care is the same for either Symbicort or Wixela. They wont step edit Symbicort because they will lose their rebate. Are u really that dumb?
No offense. Last poster clearly has no understanding of how managed care works, nor the GSK brand for generic program, which is more attractive than either SYMBICORT or WIXELA offering. Nor Mylan’s strategic ‘sweetener’ option. Good chunk of plans mandate Gx Tier 1 and brands NF, just the way it is. Another chunk of plans do indeed look at best incentives to formulary value, but GSK’s AG plan and brand for Gx give WIXELA and any other option a run for their money. Prices for ADVAIR in MEDICAID already so low, forget about it.